Best Healthcare Companies in San Diego, United States
The 406 best Healthcare companies in San Diego, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Resilience.
Ranked: Best Healthcare companies in San Diego
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Resilience Provider of supply chain services for biopharma sector 72Funding top 15%Product top 26%Innovation top 30%Growth top 35% All 9 signals ▾Fundingtop 15% Producttop 26% Innovationtop 30% Growthtop 35% Markettop 43% Techtop 43% Talentbottom 49% Globalbottom 38% Moatbottom 38% Funding: Raised $2.0B across 10 rounds · 10 rounds over 20 yrs (0.5/yr) Product: 3 distinct product lines · Company stage: Series D rank vs industry peers · Fliar Intelligence Index 72/100 | $2.0B | 7 mo ago | 1,767 | 1995 | Rahul Singhvi ex-Co-Founder | — | 1 expansion |
| 2 | AMN Healthcare Provider of medical staffing services | $1.4B | 80 mo ago | 4,230 4,230 → 6,829 (+61%) · sector median +8% | 1985 | — | — | 1 award |
| 3 | Ligand Pharmaceuticals Manufacturer of drugs | $895M | 97 mo ago | 76 76 → 136 (+79%) · sector median +8% | 1987 | Todd Davis Chief Executive Officer & Director | — | — |
| 4 | Cortica Provider of behavioral and developmental therapy services for autism 57AI top 15%Funding top 19%Product top 34%Talent top 34% All 12 signals ▾AItop 15% Fundingtop 19% Producttop 34% Talenttop 34% Techtop 45% Moatbottom 49% Patentsbottom 47% Marketbottom 45% Growthbottom 45% Innovationbottom 42% Globalbottom 38% Newsbottom 21% AI: Holds AI/ML patents (G06N-family CPC) Funding: Raised $215M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 57/100 | $215M | 19 mo ago | 296 | 2015 | Suzanne Goh Co-Founder & CMO | 13 patents AI-powered multimedia analysis for personalized augmented reality and content linking | 1 partnership · 2 expansions |
| 5 | Millenium Health Systems Drug testing laboratory empowering clinicians with comprehensive data insights for patient care | $196M | 190 mo ago | 484 | 2007 | — | — | — |
| 6 | Veterans Medical Research Foundation Provider of research funding for veteran health enhancement | $178M | 6 mo ago | 116 | 1989 | — | — | — |
| 7 | Arena Pharmaceuticals Premier biopharmaceutical company dedicated to innovative medicines and healthcare solutions | $169M | 173 mo ago | 257 | 1997 | — | — | — |
| 8 | Societal CDMO Provider of clinical trial, formulation development, packaging, and quality assurance services | $141M | 102 mo ago | 275 | 1982 | — | — | — |
| 9 | Cullgen Biopharmaceutical company pioneering targeted protein degradation for innovative medicines | $121M | 37 mo ago | 5 | 2018 | Yue Xiong Co-Founder | 4 patents Small‑molecule oncology drugs and targeted protein degraders for cancer therapy | — |
| 10 | AnaptysBio Developer of immunology therapeutics for cancer and inflammatory diseases | $86M | 131 mo ago | 101 101 → 74 (-27%) · sector median +8% | 2005 | — | 326 patents Therapeutic antibodies/modulators targeting immune checkpoints and cytokine receptors for inflammation | 1 launch |
| 11 | Salma Health Clinic chains providing personalized and connected brain and mental healthcare 67Tech top 36%Funding top 38%Talent bottom 49%Global bottom 48% All 4 signals ▾Techtop 36% Fundingtop 38% Talentbottom 49% Globalbottom 48% Tech: 30 technologies across 4/8 capability areas · Cloud: Amazon Web Services, Cloudflare Funding: Raised $80.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 67/100 | $80M | 3 mo ago | — | 2025 | Brandon Bentzley Co-Founder & Chief Medical Officer | — | — |
| 12 | Accumen Provider of healthcare consulting services | $80M | 89 mo ago | 313 | 2003 | — | 4 patents Patents concentrated in computing, sensing & instrumentation | — |
| 13 | TargeGen Small molecule kinase inhibitors that target vascular leakage (edema), vascular proliferation (angiogenesis)… | $74M | 201 mo ago | 5 | 2002 | Peter Herstall Ulrich Founder & CEO | 173 patents Small-molecule kinase inhibitors for treating myelofibrosis and other hematologic diseases | — |
| 14 | QuidelOrtho Provider of diagnostic healthcare products, ranging from home to hospital use | $69M | 53 mo ago | 7,000 | 1937 | Douglas Bryant CEO | — | 1 job opening |
| 15 | Mast Therapeutics Develops therapies for serious or life-threatening diseases using MAST technology | $63M | 117 mo ago | 38 | 1995 | — | — | — |
| 16 | Bird Rock Bio Antibody therapeutics to G-Protein Coupled Receptors targets validated with small molecules | $63M | 113 mo ago | 14 | 2008 | — | — | — |
| 17 | Concert Health Provider of consulting services for healthcare sector | $58M | 10 mo ago | 68 | 2016 | Spencer Hutchins Co-Founder & CEO | — | — |
| 18 | Pleno Standalone liquid biopsy laboratory | $55M | 18 mo ago | 47 | 2017 | Vik Vaz Chief Executive Officer | 44 patents Advanced molecular diagnostics and sequencing technologies for target biomolecule identification. | 3 job openings |
| 19 | Protego Biopharma Company developing novel therapeutics based on human genetic links | $52M | 55 mo ago | 24 | 2017 | — | 39 patents Small-molecule IRE1/XBP1 activators and diagnostics for light-chain amyloidosis | 3 job openings |
| 20 | Emerald Health Pharma Speciality company developing proprietary cannabinoid-derived medicines | $52M | 61 mo ago | 21 | 2017 | — | — | — |
| 21 | Certis Oncology Solutions Provider of oncology-based in-vivo drugs development services | $42M | 29 mo ago | 41 41 → 39 (-5%) · sector median +8% | 2016 | James Berglund Founder & Director | 12 patents Patents concentrated in computing, sensing & instrumentation | 1 partnership |
| 22 | Optimer Pharmaceuticals Limited information available | $40M | 201 mo ago | 281 | 1998 | — | 152 patents Fidaxomicin-based antibiotics for treating Clostridioides difficile and recurrent bacterial infections | — |
| 23 | Solstice Biologics Providing solutions for targeting and delivering nucleic acid therapeutics | $40M | 126 mo ago | 4,443 | 2012 | — | 9 patents Modified oligonucleotide synthesis using chiral phosphoramidite auxiliaries for therapeutic nucleic acids | — |
| 24 | MedCrypt Provider of medical device cybersecurity solutions | $36M | 16 mo ago | 21 21 → 29 (+38%) · sector median +8% | 2016 | Mike Kijewski CEO | — | — |
| 25 | Ocelot Bio CDMO focused on manufacturing of peptides | $36M | 62 mo ago | 20 | 2020 | — | — | — |
| 26 | BioIntervene Limited information available | $36M | 59 mo ago | — | 2014 | Daniela Salvemini Co-Founder | 13 patents Design and synthesis of therapeutic adenosine analogs and A3 receptor agonists. | — |
| 27 | Inception Therapeutics Provider of biopharma consulting services | $35M | 126 mo ago | 25 | 2011 | — | — | — |
| 28 | Patara Pharma Immunomodulators (mast cell stabilizers) for allergic & inflammatory diseases. | $34M | 116 mo ago | — | 2013 | William Gerhart CEO and Founder | — | — |
| 29 | Sorriso Pharmaceuticals R&D company focused on manufacturing disease-modifying antibodies for multiple therapeutics areas | $31M | 53 mo ago | 8 | 2020 | Ciara Kennedy President & Chief Executive Officer | — | — |
| 30 | Retrophin Drugs for the treatment of debilitating and often life-threatening diseases . | $29M | 152 mo ago | 380 | 2011 | Eric Dube CEO | 90 patents Small-molecule therapeutics for rare kidney and collagen disorders, plus vitamin B5 analog formulations | — |
| 31 | Cellibre Producer of cellular agricultural products | $25M | 14 mo ago | 26 | 2017 | — | 35 patents Microbial cell engineering and enzymatic biosynthesis of cannabinoids and bakuchiol. | — |
| 32 | Anabios Human tissue and cell provider accelerating drug discovery and development | $25M | 48 mo ago | 51 51 → 38 (-25%) · sector median +8% | 2009 | — | 15 patents Cardiac safety pharmacology predictive models and ex‑vivo sensory neuron subtype profiling | — |
| 33 | Sophiris Bio Develop engineered proteins to treat urological diseases and prostate cancer | $23M | 81 mo ago | 6 | 2003 | — | — | — |
| 34 | ProciseDx Provider of a point-of-care clinical diagnosis device for healthcare professionals | $22M | 59 mo ago | 25 | 2018 | — | 36 patents Immunoassay diagnostics for vascular biomarkers, therapeutic antibodies, and viral antibodies. | — |
| 35 | Headlight Mental health company that aims to simplify patients' mental health journey through a clinician-centered model | $18M | 28 mo ago | — | 2020 | Shashita Inamdar Co-Founder | — | — |
| 36 | Mindera Health Standalone clinical laboratory | $17M | 29 mo ago | 22 | 2013 | Tahir Mahmood Co-Founder | — | — |
| 37 | Guardion Health Sciences Developer of clinically supported dietary supplements for ocular health | $16M | 70 mo ago | 12 | 2009 | Michael Favish CEO & President | — | — |
| 38 | Ainos Company focused on the development of novel point-of-care testing and low-dose interferon therapeutics | $13M | 25 mo ago | 43 | 1986 | Chun Tsai CEO | 24 patents Electronic nose and gas‑sensor systems for rapid chemical/medical diagnostics | — |
| 39 | Orphagen Pioneering small molecule therapies for cancer and inflammatory bowel disease | $12M | 18 mo ago | 7 | 2001 | — | — | — |
| 40 | AseptiScope Provider of infection prevention solutions for medical stethoscopes | $9M | 63 mo ago | 10 10 → 12 (+20%) · sector median +8% | 2016 | — | 16 patents Disposable dispenser systems for sterile medical instrument and stethoscope covers | 1 award |
| 41 | Presidium Health Provider of nursing care services at home | $9M | 66 mo ago | 60 | 2015 | — | — | — |
| 42 | NanoImaging Services Provider of cryo-electron microscopy, protein production, and nanoparticle characterization services | $9M | 21 mo ago | 44 44 → 40 (-9%) · sector median +8% | 2007 | Clint Potter Co-Founder | 2 patents Electron microscopy and image analysis for particulate characterization | 1 launch |
| 43 | Excellos CDMO focused on providing manufacturing services for cell & gene therapy products | $5M | 25 mo ago | 32 | 2010 | David Wellis CEO | — | — |
| 44 | Elevate Manufacturer of devices for orthopedic industry 53Growth top 35%Talent top 38%Funding top 47%Market bottom 45% All 6 signals ▾Growthtop 35% Talenttop 38% Fundingtop 47% Marketbottom 45% Techbottom 43% Globalbottom 25% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 53/100 | $4M | 5 mo ago | 23 | 2017 | Arni Thor Co-Founder | — | — |
| 45 | Cellebration Life Sciences Provider of research, development, and manufacturing services for biologic drugs | $3M | 34 mo ago | 8 | 2019 | Tim Kopatich Co-Founder & CEO | — | — |
| 46 | PhenoVista High-content imaging and analysis services to accelerate drug discovery | $3M | 41 mo ago | 36 | 2014 | — | — | — |
| 47 | Hempacco Manufacturer of innovative, filtered hemp smokable products disrupting the tobacco industry | $2M | 26 mo ago | — | 2019 | Sandro Piancone Founder & CEO | — | — |
| 48 | Quasar Innovating dry EEG sensors and psychophysiological monitoring systems for diverse applications | $1M | 16 mo ago | — | 1997 | Walid Soussou CEO | 7 patents Patents concentrated in health & consumer products | — |
| 49 | Percept Provider of drug repurposing engine for combination therapeutics clinical development | $570K | 14 mo ago | — | 2023 | Thomas Zheng Co-Founder | 30 patents Adaptive personalized optical eyewear integrating eye‑tracking, display and vision‑enhancement technologies. | — |
| 50 | Home Care Placement Provider of in-home care services for the elderly and individuals 27Growth top 35%Talent top 45%Funding bottom 44%Tech bottom 44% All 6 signals ▾Growthtop 35% Talenttop 45% Fundingbottom 44% Techbottom 44% Globalbottom 25% Marketbottom 16% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 27/100 | $100K | 1 mo ago | — | 2022 | Diego Chacon Co-Founder | — | — |
Top 12 Healthcare companies in San Diego
#1
Series D · San Diego, California · founded 1995 · 1767 employees$2Braised▾
Provider of supply chain services for biopharma sector
- Oct 2025Venture Debt$825M
- Oct 2024Grant (prize money)$17.5M
- Mar 2023Conventional Debt$410M
- Jan 2023Series D—
#2
Funding Raised · San Diego, California · founded 1989 · 116 employees$177.9Mraised▾
Provider of research funding for veteran health enhancement. It funds research and education initiatives focused on improving the health of veterans across generations. The organization addresses health concerns disproportionately affecting veterans through scientific inquiry and discovery. Its mission is to ensure veterans receive exceptional care by supporting research that leads to better treatments and improved health outcomes.
- Dec 2025Grant (prize money)$2M
- Sep 2025Grant (prize money)$405.6K
- May 2025Grant (prize money)$369K
- May 2025Grant (prize money)$3.3M
#3
Series A · San Diego, California · founded 2025$80Mraised▾
Clinic chains providing personalized and connected brain and mental healthcare. They offer advanced diagnostics, treatments, and continuous support. The organization delivers evidence-based support throughout each stage to ensure progress. The team designs personalized plans that evolve, combining science, technology, and compassion.
- Feb 2026Series A$80M
#4
Series B · San Diego, California · founded 2016 · 68 employees$57.8Mraised▾
Provider of consulting services for healthcare sector
- Aug 2025Grant (prize money)$700K
- Apr 2025Grant (prize money)$700K
- 2024Grant (prize money)$350K
- Apr 2022Series B$42M
#5
Series D · San Diego, California · founded 2015 · 296 employees$214.7Mraised▾
Provider of behavioral and developmental therapy services for autism
- Nov 2024Series D$81M
- Oct 2023Series D$40M
- Apr 2023Series D$114.7M
- Apr 2022Series C—
#6
Series A · San Diego, California · founded 2017 · 23 employees$4.3Mraised▾
Manufacturer of devices for orthopedic industry
- Jan 2026Series A$500K
- Jan 2022Series A$4.3M
#7
Series A · San Diego, California · founded 2017 · 26 employees$25.4Mraised▾
Producer of cellular agricultural products
- Apr 2025Grant (prize money)$2M
- Sep 2024Series A$6.7M
- May 2024Grant (prize money)$1000K
- Oct 2021Series A$11.5M
#8
Series B · San Diego, California · founded 2016 · 21 employees$36.4Mraised▾
Provider of medical device cybersecurity solutions
- Feb 2025Conventional Debt$8.3M
- Jan 2023Series B—
- Nov 2022Series B$25.2M
- Oct 2022Series B$25M
#9
Series B · San Diego, California · founded 2017 · 47 employees$55Mraised▾
Standalone liquid biopsy laboratory
- Dec 2024Series B$25M
- Oct 2022Series A$40M
- May 2022Seed$15M
#10
Funding Raised · San Diego, California · founded 2001 · 7 employees$12.3Mraised▾
Pioneering small molecule therapies for cancer and inflammatory bowel disease. This company is dedicated to discovering and developing novel therapies for cancer and other serious diseases. They focus on small molecule drugs that target novel members of the nuclear receptor superfamily, a proven class for treating inflammation, oncology, and metabolic disorders. Their pipeline includes first-in-class programs in preclinical and clinical development, with a focus on oncology (including adrenal, head & neck, and squamous cancers) and inflammatory bowel disease (ulcerative colitis and Crohn’s disease). They actively engage with clinical, scientific, investment, and patient communities to advance new therapeutic approaches. Their mission is translational drug discovery and development, leading to first-in-class therapeutics. They are drug hunters committed to bringing innovative treatments to patients in need.
- Dec 2024Grant (prize money)$1.7M
- Sep 2024Grant (prize money)$1.1M
- Jul 2021Grant (prize money)$2M
- Aug 2019Grant (prize money)$1.8M
#11
Seed · San Diego, California · founded 2022$100Kraised▾
Home Care Placement is dedicated to providing world-class customer service to families with a compassionate approach. Their services aim to improve patient outcomes through in-home care, care management, and placement assistance.
- Apr 2026Seed$15K
- Apr 2026Seed$295K
- Mar 2022Seed$100K
#12
Series A · San Diego, California · founded 2007 · 44 employees$9Mraised▾
Provider of cryo-electron microscopy, protein production, and nanoparticle characterization services. They offer structural biology solutions, including sample preparation and computational infrastructure. The company’s services support structure-based drug design. They also offer method validation services.
- Sep 2024Series A$12.2M
- Jun 2023Series A—
- Jun 2021Grant (prize money)$1.1M
- Jun 2014Grant (prize money)$223.2K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising